Conference Participants
By Rick Doblin
- Psychiatrists Aron Belkin, Lev Gertsik, Ivan Barkov and Nicholai
Kharisov and psychologist/translator Alla Malushina from Moscow
- Psychiatrists Zdenek Dytrych and Jan Prasko from Prague's Psychiatric
Research Institute
- Psychiatrists Jorg Roth, Peter Bauman and Juri Styk of the Swiss
Association for Psycholytic Therapy (SAPT) (five of whose members have
been legally permitted for several years to use MDMA and LSD in
psychotherapy)
- German psychiatrist Peter Hess, German psychologist and vice-president
of the European Congress for the Study of Consciousness Michael
Schlichting, German consultant to several Swiss pharmaceutical companies
investigating the commercial potential of psychoactive drugs Andres Giger
- US psychiatrists Charles Grob and Gary Bravo from the University of
California at Irvine (who are preparing an application to the FDA to
research the psychotherapeutic use of MDMA in terminal patients)
- US experts in MDMA neurotoxicity Lewis Seiden, Ph.D. and Dr. George
Ricaurte
- US social scientists exploring MDMA's non-medical use, abuse
potential, and medical use Deborah Harlow, M.A. and Jerome Beck, Ph.D.
- US LSD researchers psychologist Richard Yensen, Ph.D. and psychiatrist
Donna Dryer
- US drug policy expert Mark Kleiman,Ph.D.
- Swiss drug abuse physician Dr. Robert Hemmig
- Teacher of zen meditation Vanya Palmer
- Inventor of LSD Albert Hofmann, Ph.D.
- Representing MAPS, myself.
